Literature DB >> 24803373

BCG, Latitude, and Environmental Mycobacteria.

C Fordham von Reyn1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24803373     DOI： 10.1093/cid/ciu331

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner.

Authors:  Valerie Acm Koeken; L Charlotte J de Bree; Vera P Mourits; Simone Jcfm Moorlag; Jona Walk; Branko Cirovic; Rob Jw Arts; Martin Jaeger; Helga Dijkstra; Heidi Lemmers; Leo Ab Joosten; Christine S Benn; Reinout van Crevel; Mihai G Netea
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 2.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

3.  Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.

Authors:  C Fordham von Reyn; Timothy Lahey; Robert D Arbeit; Bernard Landry; Leway Kailani; Lisa V Adams; Brenda C Haynes; Todd Mackenzie; Wendy Wieland-Alter; Ruth I Connor; Sue Tvaroha; David A Hokey; Ann M Ginsberg; Richard Waddell
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

4.  Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype.

Authors:  Clare M Smith; Megan K Proulx; Andrew J Olive; Dominick Laddy; Bibhuti B Mishra; Caitlin Moss; Nuria Martinez Gutierrez; Michelle M Bellerose; Palmira Barreira-Silva; Jia Yao Phuah; Richard E Baker; Samuel M Behar; Hardy Kornfeld; Thomas G Evans; Gillian Beamer; Christopher M Sassetti
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.